A newly published study in the Journal of Cancer Survivorship has shown the prevalence and motivations behind cannabis use among individuals who have battled cancer.
About The Study
- Conducted at a comprehensive cancer center in Houston, Texas, the research enlisted 1,886 participants from 41 U.S. states undergoing cancer treatment.
- Notably, the study found that 17.4% of respondents were current cannabis users, 30.5% were former users, and 52.2% had never used marijuana.
- Among the 510 participants who turned to cannabis after their cancer diagnosis, 60% cited managing sleep disturbances, 51% pain, 44% stress, 34% nausea, and 32% mood disorders or depression as reasons, as reported by Marijuana Moment.
See Also: BREAKING: Ibogaine Therapy Show Promising Outcomes For Veterans With Trauma Brain Injury
Cannabis As Symptomatic Relief: A Closer Look
Encouragingly, a substantial proportion reported significant symptomatic improvement, with 47.7% finding marijuana effective for cancer itself to a great extent, and 74% of those using it for nausea and vomiting perceiving substantial benefits.
However, the study unveiled a low awareness of potential health risks associated with cannabis use during cancer treatment. Only 1 in 10 participants were aware of such risks, including suicidal thoughts (5%), intense nausea and vomiting (6%), depression (11%), anxiety (14%), breathing problems (31%), and drug interactions (35%).
Author Recommendations: Policy And Education
Researchers from the University of Texas’s MD Anderson Cancer Center emphasized the immediate need for medical guidance on cannabis use within the broader context of cancer treatment.
"With most survivors reporting benefits from cannabis use in cancer management, there is a need for more studies to strengthen current evidence on cannabis therapeutics," they stressed, also calling for the development of policies, clear guidelines, and educational programs for healthcare providers and survivors regarding the use, benefits, and risks of cannabis in cancer management.
As the medical community navigates these findings, notable industry players, including Verano Holdings Corp. VRNOF and TILT Holdings Inc. TLLTF, along with its subsidiary Standard Farms, have recently contributed to breast cancer awareness initiatives.
Image by El Planteo
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.